Reuters

04 Jun 2026, 18:40 UTC · 1h ago

Otsuka says kidney disease drug preserves function in late-stage study

Read original · https://www.reuters.com/business/healthcare-pharmaceuticals/otsuka-says-kidney-disease-drug-preserves-function-late-stage-study-2026-06-04/

Search tags

Story key points

1 claims · impact-rated

What matters in this story

1
Otsuka Pharmaceutical's drug preserved kidney function over 12 months in a late-stage study for a specific autoimmune disease. — Positive late-stage clinical results significantly increase the probability of regulatory approval and future revenue streams for the company.
+0.60

Ticker attribution

Model heads

Sentiment in this article

4578+0.80
The company reported positive results from a late-stage study showing its drug preserved kidney function in patients.

Relationships in this article

No ticker relationship head found.

Early access

You’re reading about it. Someone else is already positioned.

News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.

4578

Browse live screenings

Impact vectors

2 dimensions · 9 clusters

6 related stories

PRNewsWire
8h ago
Jazz Pharmaceuticals to Present Comprehensive Data at SLEEP 2026 Highlighting Broad Treatment Effects of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for People with Narcolepsy and Idiopathic Hypersomnia
- drug trial
- healthcare
- pharmaceuticals
Read

Otsuka says kidney disease drug preserves function in late-stage stud… · News Impact Screener

Otsuka says kidney disease drug preserves function in late-stage study

What matters in this story

Sentiment in this article

Relationships in this article

You’re reading about it. Someone else is already positioned.

Jazz Pharmaceuticals to Present Comprehensive Data at SLEEP 2026 Highlighting Broad Treatment Effects of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for People with Narcolepsy and Idiopathic Hypersomnia

Otsuka says kidney disease drug preserves function in late-stage study

What matters in this story

Sentiment in this article

Relationships in this article

You’re reading about it. Someone else is already positioned.

Jazz Pharmaceuticals to Present Comprehensive Data at SLEEP 2026 Highlighting Broad Treatment Effects of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for People with Narcolepsy and Idiopathic Hypersomnia

Analytical profile by cluster

Top impact dimensions

Most positively impacted

Most negatively impacted

Amgen Inc. (AMGN) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Inovio Pharmaceuticals, Inc. (INO) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Roche rapidly develops a PCR test for Ebola within six days as rare Bundibugyo virus drives urgent need for detection

Arch Biopartners Featured in American Diabetes Association Thought Leadership Series at the 2026 Scientific Sessions in New Orleans

DaltonTx launches its drug discovery platform, Dalton, and announces Sygnature Discovery collaboration

Otsuka says kidney disease drug preserves function in late-stage study

What matters in this story

Sentiment in this article

Relationships in this article

You’re reading about it. Someone else is already positioned.

Next reads from the same story arc

Jazz Pharmaceuticals to Present Comprehensive Data at SLEEP 2026 Highlighting Broad Treatment Effects of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for People with Narcolepsy and Idiopathic Hypersomnia

Otsuka says kidney disease drug preserves function in late-stage study

What matters in this story

Sentiment in this article

Relationships in this article

You’re reading about it. Someone else is already positioned.

Next reads from the same story arc

Jazz Pharmaceuticals to Present Comprehensive Data at SLEEP 2026 Highlighting Broad Treatment Effects of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for People with Narcolepsy and Idiopathic Hypersomnia

Analytical profile by cluster

Top impact dimensions

Most positively impacted

Most negatively impacted

Amgen Inc. (AMGN) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Inovio Pharmaceuticals, Inc. (INO) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Roche rapidly develops a PCR test for Ebola within six days as rare Bundibugyo virus drives urgent need for detection

Arch Biopartners Featured in American Diabetes Association Thought Leadership Series at the 2026 Scientific Sessions in New Orleans

DaltonTx launches its drug discovery platform, Dalton, and announces Sygnature Discovery collaboration